According to filings with the U.S. Securities and Exchange Commission, Earlens is raising up to $43,571,345.00 in new funding. Sources indicate that as part of senior management President and Chief Executive Officer, William Facteau played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Earlens
Earlens is a privately held medical technology company committed to transforming the hearing experience for millions of people who suffer from hearing loss. The company has developed the Earlens Contact Hearing Solution, which directly vibrates the eardrum with a tiny lens in order to activate the natural hearing process. This revolutionary, nonsurgical hearing solution delivers the broadest bandwidth available today and superior sound quality. The Earlens Contact Hearing Solution received FDA clearance in 2019 for a second generation of the Earlens technology. We believe that people with hearing loss shouldnt have to think about their hearing in everyday situations. Earlens was designed specifically to address the sound quality and speech understanding complaints that are common among hearing aid wearers and contribute to non-compliance. We make every Earlens device custom-fit for each patients unique anatomy and hearing needs, while offering modern features such as Bluetooth streaming.

To learn more about Earlens, visit http://www.earlens.com/

Contact:
William Facteau, President and Chief Executive Officer
650-366-9000
https://www.linkedin.com/in/bill-facteau-5430042/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.